Novo Nordisk A/S
NONOF
$49.68
$0.160.32%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.48% | 10.95% | 24.06% | 15.82% | 20.61% |
| Total Depreciation and Amortization | 80.19% | 98.19% | 65.49% | 30.38% | 16.84% |
| Total Amortization of Deferred Charges | 36.01% | 18.52% | 18.52% | 18.52% | 18.52% |
| Total Other Non-Cash Items | -127.93% | -68.42% | -50.06% | 128.37% | -69.30% |
| Change in Net Operating Assets | 161.31% | 86.65% | -890.38% | 66.87% | 116.06% |
| Cash from Operations | 2.80% | 8.38% | 6.93% | 39.31% | 11.11% |
| Capital Expenditure | -33.66% | -45.36% | -65.74% | -74.13% | -82.46% |
| Sale of Property, Plant, and Equipment | -- | -196.95% | -- | -- | -- |
| Cash Acquisitions | 101.33% | -11,983.50% | -11,983.50% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7,604.41% | 200.60% | 144.40% | -51.64% | 101.63% |
| Cash from Investing | 34.18% | -143.57% | -196.96% | -314.30% | -190.78% |
| Total Debt Issued | 30.91% | 240.93% | 240.38% | -- | -- |
| Total Debt Repaid | -1,150.01% | -1,154.08% | -1,200.60% | -1,282.08% | -331.83% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 93.12% | 60.45% | 56.91% | 32.03% | 32.56% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -17.53% | -17.53% | -18.84% | -18.84% | -40.21% |
| Other Financing Activities | -- | -- | -- | 1,008.73% | -- |
| Cash from Financing | -488.76% | 34.41% | 35.92% | 157.07% | 112.20% |
| Foreign Exchange rate Adjustments | -271.16% | 66.65% | -294.17% | 62.40% | 485.36% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 491.38% | -192.12% | -213.65% | 482.86% | -12.51% |